SERPINA1 and alpha 1-antitrypsin deficiency: Treatment of the lung manifestations of AAT deficiency includes many standard therapies for chronic obstructive pulmonary disease (COPD) in addition to ”augmentation therapy” with human plasma-derived, purified AAT.